Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Finke

Showing results (161-170 of 180) with videos related to

Pageof 18
Sort By:
American Journal of Hematology|January 12, 2020
Phenotypic correlates and prognostic outcomes of TET2 mutations in myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: A comprehensive study of 504 adult patientsGiacomo Coltro, Guadalupe Antelo, Terra L Lasho, et al.
Nature Communications|March 18, 2022
Oncogenic gene expression and epigenetic remodeling of cis-regulatory elements in ASXL1-mutant chronic myelomonocytic leukemiaMoritz Binder, Ryan M Carr, Terra L Lasho, et al.
Leukemia|March 28, 2013
Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomesM M Patnaik, E Padron, R R LaBorde, et al.
Leukemia|June 11, 2013
AKT is a therapeutic target in myeloproliferative neoplasmsI Khan, Z Huang, Q Wen, et al.
Blood Cancer Journal|February 14, 2018
Prognostic interaction between bone marrow morphology and SF3B1 and ASXL1 mutations in myelodysplastic syndromes with ring sideroblastsAbhishek A Mangaonkar, Terra L Lasho, Christy M Finke, et al.
Leukemia|March 6, 2009
TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosisA Tefferi, A Pardanani, K-H Lim, et al.
American Journal of Hematology|September 27, 2024
PHF6 mutations in chronic myelomonocytic leukemia identify a unique subset of patients with distinct phenotype and superior prognosisAyalew Tefferi, Saubia Fathima, Ali Khalid A Alsugair, et al.
Blood Advances|March 31, 2026
Rapid Germline Testing with Hair Root Bulb-Derived DNA for Hereditary Predisposition and Inherited Marrow Failure StatesEmma C St Martin, Abhishek A Mangaonkar, Ann M Moyer, et al.
Leukemia|December 15, 2019
Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)-a study of 1084 patientsGiacomo Coltro, Abhishek A Mangaonkar, Terra L Lasho, et al.
American Journal of Hematology|September 4, 2023
Patients with telomere biology disorders show context specific somatic mosaic states with high frequency of U2AF1 variantsAlejandro Ferrer, Terra Lasho, Jenna A Fernandez, et al.
Pageof 18

Showing results (161-170 of 180) with videos related to

Sort By:
Pageof 18
American Journal of Hematology|January 12, 2020
Phenotypic correlates and prognostic outcomes of TET2 mutations in myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: A comprehensive study of 504 adult patientsGiacomo Coltro, Guadalupe Antelo, Terra L Lasho, et al.
Nature Communications|March 18, 2022
Oncogenic gene expression and epigenetic remodeling of cis-regulatory elements in ASXL1-mutant chronic myelomonocytic leukemiaMoritz Binder, Ryan M Carr, Terra L Lasho, et al.
Leukemia|March 28, 2013
Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomesM M Patnaik, E Padron, R R LaBorde, et al.
Leukemia|June 11, 2013
AKT is a therapeutic target in myeloproliferative neoplasmsI Khan, Z Huang, Q Wen, et al.
Blood Cancer Journal|February 14, 2018
Prognostic interaction between bone marrow morphology and SF3B1 and ASXL1 mutations in myelodysplastic syndromes with ring sideroblastsAbhishek A Mangaonkar, Terra L Lasho, Christy M Finke, et al.
Leukemia|March 6, 2009
TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosisA Tefferi, A Pardanani, K-H Lim, et al.
American Journal of Hematology|September 27, 2024
PHF6 mutations in chronic myelomonocytic leukemia identify a unique subset of patients with distinct phenotype and superior prognosisAyalew Tefferi, Saubia Fathima, Ali Khalid A Alsugair, et al.
Blood Advances|March 31, 2026
Rapid Germline Testing with Hair Root Bulb-Derived DNA for Hereditary Predisposition and Inherited Marrow Failure StatesEmma C St Martin, Abhishek A Mangaonkar, Ann M Moyer, et al.
Leukemia|December 15, 2019
Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)-a study of 1084 patientsGiacomo Coltro, Abhishek A Mangaonkar, Terra L Lasho, et al.
American Journal of Hematology|September 4, 2023
Patients with telomere biology disorders show context specific somatic mosaic states with high frequency of U2AF1 variantsAlejandro Ferrer, Terra Lasho, Jenna A Fernandez, et al.
Pageof 18